Addison Disease
An adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES.
Subtype terms (1)
More specific conditions that are subtypes of Addison Disease in the MeSH hierarchy.
- Hypoadrenocorticism, Familial
4 drugs approved
Drugs by status
Approved for this indication (7)
Phase 4 trials (1)
Phase 3 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (3)
Organization Involved with Other Experimental Indications (2)